Daktronics to Present at Sidoti Small-Cap Investor Conference

Daktronics to Present at Sidoti Small-Cap Investor Conference GlobeNewswire January 14, 2026 BROOKINGS, S.D., Jan. 14, 2026 (GLOBE NEWSWIRE) — Daktronics Inc. (Nasdaq: DAKT), a leading global designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide, announced that management will present and host one-on-one meetings with investors at Sidoti's […]

My Instant AI Becomes First Company to Include Small Businesses Worldwide in AI Economy

Scottsdale-based platform launches global retail distribution in 150+ countries, enabling tens of thousands of independent retailers to earn retail margin selling cash-based AI access. My Instant AI today launched global retail distribution through EZ Pin Inc (www.ezpin.com), making it the first artificial intelligence company to include small businesses worldwide in the AI marketplace. Starting today,

Transneural Therapeutics Presents Preclinical Data on Lead Candidate TN-001 at 64th Annual Meeting of ACNP (2026)

Poster presentation highlighted promising pharmacology and behavioral results on lead candidate, TN-001, in preclinical studies. TN-001 is under development for both major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). TN-001 rapidly induces neuroplasticity, including synaptogenesis. Transneural Therapeutics, Inc. (Transneural), a neuroscience-focused biotechnology company aiming to transform the treatment of neuropsychiatric and neurodegenerative diseases with

TEAMSTERS TO MONITOR PROPOSED ALLEGIANT-SUN COUNTRY MERGER

Union Says Strong Labor Standards and Real Protections Must Guide Any Potential Deal The International Brotherhood of Teamsters is closely monitoring a proposed merger announced this week between Allegiant Air and Sun Country Airlines. The Teamsters represent over 3,000 workers across both companies, including pilots, aircraft maintenance technicians and related employees, and dispatchers at Allegiant

Enerflex Ltd. Announces Timing of Fourth Quarter Financial and Operational Results

(TSX:EFX),(NYSE:EFXT), CALGARY, Alberta, Jan. 14, 2026 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) plans to release its financial results and operating highlights for the year ended December 31, 2025, on Thursday, February 26, 2026 prior to market open. Results will be communicated by news release and will be available

AJOVY(R) (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

(NYSE:TEVA),(TASE:TEVA.TA),(TASE:TEVA), AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related peptide (CGRP) antagonist treatment option for both pediatric and adult patients.1,2 Results from the SPACE trial found AJOVY significantly reduced monthly migraine days and monthly headache days versus placebo over a 12-week period in

North Point Global Transportation Expands Group Travel Fleet with 56-, 40-, 34-, and 24-Passenger Vehicles

Atlanta, Georgia–(Newsfile Corp. – January 14, 2026) – North Point Global Transportation Services, a premier provider of luxury chauffeured transportation, today announced an expansion of its group travel fleet with new 56-passenger motor coaches, additional 40- and 34-passenger Temsa Executive Coaches, and 24-passenger minibuses. The enhanced fleet supports rising demand for corporate events, conferences, sporting

Enerflex Ltd. Announces Timing of Fourth Quarter Financial and Operational Results

Enerflex Ltd. Announces Timing of Fourth Quarter Financial and Operational Results GlobeNewswire January 14, 2026 CALGARY, Alberta, Jan. 14, 2026 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) plans to release its financial results and operating highlights for the year ended December 31, 2025, on Thursday, February 26, 2026 prior

AJOVY(R) (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

AJOVY(R) (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine GlobeNewswire January 14, 2026 AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related

THE WORLD NEEDS ECCO THE DOLPHIN

Iconic Underwater Adventurer Returns to the Deep A&R Atelier announced today that Ecco the Dolphin is officially in development. Originally released in 1992, Ecco the Dolphin garnered critical and commercial acclaim at launch. “It has been years in the making and we're honored to bring Ecco back,” said Ed Annunziata, Chief Creative Officer of A&R

Scroll to Top